These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 20097953)
1. The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase. Otocka-Kmiecik A; Orłowska-Majdak M Postepy Hig Med Dosw (Online); 2009 Dec; 63():668-77. PubMed ID: 20097953 [TBL] [Abstract][Full Text] [Related]
3. The paraoxonase 1, 2 and 3 in humans. Rajkovic MG; Rumora L; Barisic K Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851 [TBL] [Abstract][Full Text] [Related]
4. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation. Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818 [TBL] [Abstract][Full Text] [Related]
5. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae. Soran H; Schofield JD; Liu Y; Durrington PN Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614 [TBL] [Abstract][Full Text] [Related]
6. Review: The role of paraoxonase in cardiovascular diseases. Kowalska K; Socha E; Milnerowicz H Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882 [TBL] [Abstract][Full Text] [Related]
8. The growing importance of PON1 in cardiovascular health: a review. Macharia M; Hassan MS; Blackhurst D; Erasmus RT; Matsha TE J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):443-53. PubMed ID: 22673025 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease. Kim DS; Marsillach J; Furlong CE; Jarvik GP Pharmacogenomics; 2013 Sep; 14(12):1495-515. PubMed ID: 24024900 [TBL] [Abstract][Full Text] [Related]
10. Paraoxonases-1, -2 and -3: What are their functions? Furlong CE; Marsillach J; Jarvik GP; Costa LG Chem Biol Interact; 2016 Nov; 259(Pt B):51-62. PubMed ID: 27238723 [TBL] [Abstract][Full Text] [Related]
11. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Deakin SP; James RW Clin Sci (Lond); 2004 Nov; 107(5):435-47. PubMed ID: 15265000 [TBL] [Abstract][Full Text] [Related]
12. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks. Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515 [TBL] [Abstract][Full Text] [Related]
13. The paraoxonase gene family and atherosclerosis. Ng CJ; Shih DM; Hama SY; Villa N; Navab M; Reddy ST Free Radic Biol Med; 2005 Jan; 38(2):153-63. PubMed ID: 15607899 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of paraoxonases: a brief review. Draganov DI; La Du BN Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):78-88. PubMed ID: 14579013 [TBL] [Abstract][Full Text] [Related]
15. Modulation of paraoxonase (PON1) activity. Costa LG; Vitalone A; Cole TB; Furlong CE Biochem Pharmacol; 2005 Feb; 69(4):541-50. PubMed ID: 15670573 [TBL] [Abstract][Full Text] [Related]
16. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. She ZG; Chen HZ; Yan Y; Li H; Liu DP Antioxid Redox Signal; 2012 Mar; 16(6):597-632. PubMed ID: 21867409 [TBL] [Abstract][Full Text] [Related]
17. Paraoxonase-1 (PON1) Status Analysis Using Non-Organophosphate Substrates. Marsillach J; Richter RJ; Costa LG; Furlong CE Curr Protoc; 2021 Jan; 1(1):e25. PubMed ID: 33484495 [TBL] [Abstract][Full Text] [Related]